Related Experiment Videos
Benzodiazepine-receptor antagonist, a clinical double blind study
H P Aarseth1, J E Bredesen, B Grynne
1Department of clinical Pharmacology, Ullevål Hospital, Oslo, Norway.
Journal of Toxicology. Clinical Toxicology
|January 1, 1988
Summary
The first benzodiazepine antagonist rapidly reversed intoxication symptoms in a study of 18 patients. While effective, delayed clinical deterioration in some cases warrants caution for patients leaving medical care.
Area of Science:
- Pharmacology
- Toxicology
- Emergency Medicine
Background:
- Benzodiazepine intoxication presents a significant clinical challenge.
- A specific antagonist for benzodiazepines has been developed.
Purpose of the Study:
- To evaluate the efficacy and safety of the first specific benzodiazepine antagonist.
- To assess the impact on consciousness and adverse effects.
Main Methods:
- Double-blind study design.
- Inclusion of 18 patients with suspected benzodiazepine intoxication.
- Comparison of the specific antagonist against a placebo.
Main Results:
- Highly significant improvement in consciousness observed with the antagonist.
- All patients receiving the antagonist regained consciousness rapidly.
- No immediate adverse effects were noted.
Conclusions:
- The benzodiazepine antagonist demonstrates rapid efficacy in reversing intoxication.
- Delayed deterioration in a subset of patients suggests potential risks upon discharge.
- Careful monitoring is advised for patients treated with this antagonist.